Who owns BIO-TECHNE Corp (TECH)? Elite investor 13F holders

11 tracked elite investors reported holding BIO-TECHNE Corp as of 2026-06-30, including Maverick Capital, Ruane Cunniff LP, Durable Capital Partners, Mairs & Power Funds, Tudor Investment. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.

11 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences segment develops and manufactures biological reagents used in various…

Reported holders and securities, including exits (up to 20)

Reported holders and securities, including exits (up to 20)
InvestorSecurityInstrumentReport periodFiledValueQuantityUnitsChangeSource
Maverick CapitalBIO-TECHNE CORPSHARE2026-06-302026-08-14 00:00:00108490847.00 USD1535610.000000SharesreduceOriginal filing
Ruane Cunniff LPBIO-TECHNE CORPSHARE2026-06-302026-08-14 00:00:00236595617.00 USD3348841.000000SharesreduceOriginal filing
Durable Capital PartnersBIO-TECHNE CORPSHARE2026-06-302026-08-14 00:00:0035463686.00 USD501963.000000SharesreduceOriginal filing
Mairs & Power FundsBIO-TECHNE CORPSHARE2026-06-302026-08-14 00:00:00190804299.00 USD2700698.000000SharesreduceOriginal filing
Tudor InvestmentBIO-TECHNE CORPSHARE2026-06-302026-08-14 00:00:0066643227.00 USD943287.000000SharesbuyOriginal filing
Weitz Investment ManagementBIO-TECHNE CORPSHARE2026-06-302026-08-12 00:00:0038377080.00 USD543200.000000SharesreduceOriginal filing
D.E. ShawBIO-TECHNE CORPSHARE2026-06-302026-08-14 00:00:0016142042.00 USD228479.000000SharesbuyOriginal filing
Ananym CapitalBIO-TECHNE CORPSHARE2026-06-302026-08-14 00:00:008478000.00 USD120000.000000SharesbuyOriginal filing
Gotham Asset ManagementBIO-TECHNE CORPSHARE2026-06-302026-08-14 00:00:005028514.00 USD71175.000000SharesaddOriginal filing
Bridgewater AssociatesBIO-TECHNE CORPSHARE2026-06-302026-08-14 00:00:001889888.00 USD26750.000000SharesaddOriginal filing
GAMCOBIO-TECHNE CORPSHARE2026-06-302026-08-12 00:00:00441563.00 USD6250.000000SharesbuyOriginal filing
Ancora Advisors / Ancora HoldingsBIO-TECHNE CORPSHARE2026-06-302026-08-14 00:00:000.00 USD0.000000SharesexitedOriginal filing

Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.

This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.

How to read the data · Disclaimer

Read as Markdown